Vanguard Asset Management 13F: New $141M Stake in Alcon (ALC)

Vanguard Asset Management has taken a new stake in Alcon Inc. (NYSE:ALC), according to its latest Form 13F filing with the SEC. The firm acquired 2,074,627 shares, valued at approximately $141.3 million. This move reflects Vanguard's new position in the company as of the reporting period.

What Changed in Vanguard Asset Management's Alcon Inc. Position

Vanguard Asset Management opened a new position in Alcon Inc., acquiring 2,074,627 shares. This investment is valued at roughly $141.3 million, indicating a fresh interest in the eye care company.

Other Institutional Activity in Alcon Inc.

Several other institutional investors have also been active in Alcon Inc. Bank of New York Mellon Corp increased its holdings by 2,478,144 shares, bringing its total to 15,669,662 shares, worth about $1.18 billion, an 18.8% increase. Vanguard Capital Management LLC also opened a new position with 14,871,607 shares valued at $1.12 billion. Meanwhile, FMR LLC added 1,668,163 shares, ending with 12,426,992 shares valued at $938.3 million, marking a 15.5% increase. On the other hand, Aristotle Capital Management, LLC reduced its stake by 481,233 shares to a total of 10,584,374 shares, worth $796.2 million, a 4.3% decrease.

Alcon Inc. Stock Up 4.8%

Shares of NYSE:ALC traded near $68.13 on Friday. Alcon Inc. has a market capitalization of approximately $33.2 billion. The company's forward P/E ratio stands at 17.2, and it has a beta of 0.698, indicating less volatility compared to the market. The stock's 52-week range is between $61.84 and $92.55, with a 50-day moving average of $68.97 and a 200-day moving average of $75.80.

Recent Earnings

Alcon Inc. reported revenue of $10.63 billion, achieving a growth rate of 9.4%. The company's earnings per share (EPS) is $1.67, with a net margin of 7.7% and a return on equity (ROE) of 3.7%. The next earnings report is scheduled for August 10, 2026.

Dividend

Alcon Inc. offers an annual dividend rate of $0.36, yielding 0.53%. The dividend payout ratio is 20.39%.

Insider Buying and Selling at Alcon Inc.

Several insiders have sold shares of Alcon Inc. Sergio Duplan sold 15,000 shares on February 26, 2026, at an average price of $86.54. Laurent Attias also sold 2,412 shares on the same day at $86.91. Earlier, on March 3, 2025, Duplan sold 12,600 shares at prices of $93.2 and $93.0, with the latter being a planned sale. Timothy Stonesifer sold 20,000 shares on February 28, 2025, at prices of $92.09 and $92.0, with the latter transaction also planned.

Analysts Set New Price Targets

Analysts have maintained their ratings on Alcon Inc. On May 8, 2026, Barclays kept a 'hold' rating with a price target of $78. Wells Fargo and Mizuho both maintained 'buy' ratings with targets of $86 and $85, respectively, on May 7, 2026. Baird also maintained a 'buy' rating, setting a target of $90 on the same day. The consensus recommendation is a 'buy', with a mean target price of $87.92 from 15 analyst opinions.

About Alcon Inc.

Alcon Inc., headquartered in Geneva, Switzerland, is a global leader in eye care. The company specializes in surgical and vision care products, including equipment, intraocular lenses, and contact lenses. Under the leadership of CEO David J. Endicott, Alcon employs around 25,000 people worldwide, focusing on innovative solutions for eye health.

Bottom Line

Vanguard Asset Management's new stake in Alcon Inc. highlights its interest in the healthcare sector, particularly eye care. Investors often track such institutional moves for insights, though it's important to remember that 13F filings are backward-looking and may not reflect current positions. Alcon's stock performance and analyst ratings suggest continued interest in its growth potential.